| Autor: |
Kibler, M. L., Pendell, D. L., Costanigro, M., Traub‐Dargatz, J. |
| Zdroj: |
Equine Veterinary Journal; Jul2018, Vol. 50 Issue 4, p498-503, 6p |
| Abstrakt: |
Summary: Background: Equine injury and disease cause two types of costs for those financially responsible for treating and caring for the infected horse(s); direct costs of treating the horse and indirect cost of lost use of the horse for a period of time to the user of the horse (daily horse use). Indirect costs are more difficult to estimate but pose significant financial implications for equine‐owners/caregivers. Additionally, there exists a gap in existing research regarding the valuation of infectious treatment options in horses. Objective: To estimate the value a US horse‐owner/caregiver places on daily horse use and describe respondents’ willingness‐to‐pay for various attributes of equine treatment options. Study design: Online questionnaire survey. Methods: An online questionnaire was provided to equine‐owners and caretakers, and owner demographic, horse care and horse use information from respondents were requested. Additionally, respondents were presented with hypothetical disease treatment options with the following attributes: daily dosage, number of days of rest required, route of administration and out‐of‐pocket cost to the owner/caretaker through a choice experiment. Data were analysed using a rank‐ordered logit analysis and willingness‐to‐pay estimates for daily use and treatment options were calculated. Results: Results suggest that the average horse‐owner with an uninsured and insured horse is willing to pay $12.07 (95% confidence interval: −$15.01, −$9.69) and $17.95 (95% confidence interval: −$25.30, −$11.20) per day to reduce lost use days required (due to need for rest) respectively. Respondents showed preferences for oral administration over treatments requiring i.m. injections. Main limitations: As this study employed an online survey it was subjected to self‐selection bias and a sample size calculation was not performed. Conclusions: Veterinarians and pharmaceutical companies may use these results when promoting various treatment options to horse‐owners/caregivers and in product development. Additionally, promotion efforts may be targeted towards equine‐owners with higher daily use values (owners with insured horses). [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text